The pattern of KRAS mutations in non-small cell lung cancer (NSCLC): A retrospective study from south-eastern Georgia.

被引：0
|
作者：
Matosz, Sabrina
Elzaidy, Mostafa
Karim, Nagla Fawzy Abdel
机构：
[1] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[2] Maadi Mil Hosp, Cairo, Egypt
[3] Augusta Univ, Med Ctr, Augusta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15110
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Stella, Giulia M.
    Scabini, Roberta
    Inghilleri, Simona
    Cemmi, Francesca
    Corso, Simona
    Pozzi, Ernesto
    Morbini, Patrizia
    Valentini, Adele
    Dore, Roberto
    Ferrari, Simona
    Luisetti, Maurizio
    Zorzetto, Michele
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1327 - 1335
  • [42] The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
    Salgia, Ravi
    Pharaon, Rebecca
    Mambetsariev, Isa
    Nam, Arin
    Sattler, Martin
    CELL REPORTS MEDICINE, 2021, 2 (01)
  • [43] Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC)
    Mazieres, J.
    Tomasini, P.
    Lusque, A.
    Boucekine, M.
    Gautschi, O.
    Cortot, A. B.
    Couraud, S.
    Thai, A.
    Ng, T.
    Greillier, L.
    Veillon, R.
    Neal, J. W.
    Popat, S.
    Gounant, V.
    Mhanna, L.
    Drilon, A.
    Baron, J. Milia
    Barlesi, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S826 - S827
  • [44] Predictive value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with chemotherapy (CT)
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Mellema, Wouter
    Heideman, Danielle
    Van Suylen, Robertjan
    Thunnissen, Erik
    CANCER RESEARCH, 2011, 71
  • [45] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Giulia M. Stella
    Roberta Scabini
    Simona Inghilleri
    Francesca Cemmi
    Simona Corso
    Ernesto Pozzi
    Patrizia Morbini
    Adele Valentini
    Roberto Dore
    Simona Ferrari
    Maurizio Luisetti
    Michele Zorzetto
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1327 - 1335
  • [46] A randomized discontinuation phase II trial of ridaforolimus in non-small cell lung cancer (NSCLC) patients with KRAS mutations.
    Riely, Gregory J.
    Brahmer, Julie R.
    Planchard, David
    Crino, Lucio
    Doebele, Robert Charles
    Mas Lopez, Luis Alberto
    Gettinger, Scott N.
    Schumann, Christian
    Li, Xiaoyun
    Atkins, Barbara McCormick
    Ebbinghaus, Scot
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Kim, Seung Tae
    Sung, Jae Sook
    Jo, Uk Hyun
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [48] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Seung Tae Kim
    Jae Sook Sung
    Uk Hyun Jo
    Kyong Hwa Park
    Sang Won Shin
    Yeul Hong Kim
    Medical Oncology, 2013, 30
  • [49] Predictive value of coexisting KRAS and TP53 mutations on response to chemotherapy in non-small cell lung cancer (NSCLC).
    Tomasini, Pascale
    Jao, Kevin
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Tsao, Ming Sound
    Liu, Geoffrey
    Leighl, Natasha B.
    Feld, Ronald
    Bradbury, Penelope Ann
    Pintilie, Melania
    Mascaux, Celine
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Frequency ofEGFR and KRAS Mutations in Non-Small Cell Lung Cancer (NSCLC) in a Brazilian Population and Correlation with Genetic Ancestry Markers
    Dias, C.
    Scapulatempo, C.
    Viana, L.
    Miziara, J.
    Pereira, R.
    Reis, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 904 - 904
12345